Skip to main content
. Author manuscript; available in PMC: 2022 Apr 1.
Published in final edited form as: Curr Hematol Malig Rep. 2021 Mar 17;16(2):183–191. doi: 10.1007/s11899-021-00624-6

Table 2:

Selected Antibody-drug Conjugates Investigated in Clinical Trials in Multiple Myeloma

Agent Target Clinical Trial Phase Single vs combination
CC99712 BCMA NCT04036461 I Single
AMG 224 BCMA NCT02561962 I Single
STRO-001 CD74 NCT03424603 I Single
FOR46 CD46 NCT03650491 I Single
TAK-169 CD38 NCT04017130 I Single